Evidence map›Paper›PMID 25899817›Full record

ArticleThe EMBO journal2015

Synthetic viability genomic screening defines Sae2 function in DNA repair.

Fabio Puddu, Tobias Oelschlaegel, Ilaria Guerini, Nicola J Geisler, Hengyao Niu, Mareike Herzog, Israel Salguero, Bernardo Ochoa-Montaño, Emmanuelle Viré, Patrick Sung and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The EMBO journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Sae2 antagonizes Rad9 accumulation at DNA double-strand breaks to attenuate checkpoint signaling and facilitate end resection.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Fabio PudduThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.
Tobias OelschlaegelThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.
Ilaria GueriniThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.
Nicola J GeislerThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.
Hengyao NiuMolecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, CT, USA.
Mareike HerzogThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK The Wellcome Trust Sanger Institute, Hinxton Cambridge, UK.
Israel SalgueroThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.
Bernardo Ochoa-MontañoThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.
Emmanuelle ViréThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.
Patrick SungMolecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, CT, USA.
David J AdamsThe Wellcome Trust Sanger Institute, Hinxton Cambridge, UK.
Thomas M KeaneThe Wellcome Trust Sanger Institute, Hinxton Cambridge, UK.
Stephen P JacksonThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK The Wellcome Trust Sanger Institute, Hinxton Cambridge, UK s.jackson@gurdon.cam.ac.uk.
Wellcome/Cancer Research UK Gurdon Institute · GBWellcome Sanger Institute · GBUniversity of Cambridge · GBYale University · US

Funding

YEAST DNA REPAIR GENES AND PROTEINS OF THE RAD52 GROUPR01ES007061 · NIEHS · YALE UNIVERSITY · PI Patrick Sung · 1995 to 2026
$9.4M
Mechanisms and Crosstalk of DNA Break Resection PathwaysK99ES021441 · NIEHS · YALE UNIVERSITY · PI NIU, HENGYAO · 2012 to 2013
$180k
Cancer Research UK 11224Cancer Research UK 13031Cancer Research UK 18796Cancer Research UK C6946/A14492Cancer Research UK C6/A11224NIEHS NIH HHS K99 ES021441NIEHS NIH HHS K99ES021441NIEHS NIH HHS R01 ES007061NIEHS NIH HHS R01ES007061Wellcome Trust 101126Wellcome Trust 101126/Z/13/ZWellcome Trust WT092096Wellcome Trust WT098051
6 · The paper itself

Abstract

DNA double-strand break (DSB) repair by homologous recombination (HR) requires 3' single-stranded DNA (ssDNA) generation by 5' DNA-end resection. During meiosis, yeast Sae2 cooperates with the nuclease Mre11 to remove covalently bound Spo11 from DSB termini, allowing resection and HR to ensue. Mitotic roles of Sae2 and Mre11 nuclease have remained enigmatic, however, since cells lacking these display modest resection defects but marked DNA damage hypersensitivities. By combining classic genetic suppressor screening with high-throughput DNA sequencing, we identify Mre11 mutations that strongly suppress DNA damage sensitivities of sae2∆ cells. By assessing the impacts of these mutations at the cellular, biochemical and structural levels, we propose that, in addition to promoting resection, a crucial role for Sae2 and Mre11 nuclease activity in mitotic DSB repair is to facilitate the removal of Mre11 from ssDNA associated with DSB ends. Thus, without Sae2 or Mre11 nuclease activity, Mre11 bound to partly processed DSBs impairs strand invasion and HR.

Indexed as

DNA, FungalDNA RepairDNA, Single-StrandedEndodeoxyribonucleasesEndonucleasesExodeoxyribonucleasesHigh-Throughput Nucleotide SequencingMeiotic Recombination Protein SPO11Saccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsDNA, FungalDNA, Single-StrandedEndodeoxyribonucleasesEndonucleasesExodeoxyribonucleasesMeiotic Recombination Protein SPO11MRE11 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSAE2 protein, S cerevisiaeSpo11 protein, S cerevisiaeMre11Sae2suppressor screeningsynthetic viabilitywhole‐genome sequencing

Identifiers

PMID25899817
PMCPMC4474527
OpenAlexW1996896283

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.